Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
The article discusses the modern principles of lipid-lowering therapy and approaches to its administration in terms of levels of cardiovascular risk. The characteristics of groups of patients with different levels of cardiovascular risk (from low to high) in primary prevention are given. The article...
Saved in:
Main Authors: | Marina G. Bubnova, Marianna Y. Ilchenko, Petr A. Lebedev |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Concilium Medicum
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5f5a0142ea2a45fc9cae20eea8f53e85 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statins and diabetes: focus on pitavastatin
by: Soreiia A. Urazgildeeva
Published: (2020) -
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
by: Sydney B Long, et al.
Published: (2010) -
Impact of adherence, patient perception, and knowledge to statin therapy – A cross-sectional study
by: Siddhi Umarje, et al.
Published: (2021) -
Normative data on cardiovascular autonomic function in Greenlandic Inuit
by: Jesper Fleischer, et al.
Published: (2021) -
Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
by: Peter Rossing, et al.
Published: (2021)